Brain tumor patients get new hope to dodge deadly blood clots
NCT ID NCT05683808
Summary
This study is testing if the blood-thinning medication apixaban can safely prevent dangerous blood clots in people newly diagnosed with aggressive brain tumors (grade 4 glioma). It will involve about 40 adult patients who are starting radiation and chemotherapy. The main goal is to gather safety information, specifically checking for serious bleeding risks, while also seeing if the drug effectively prevents clots.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.